entertainment -WSS

entertainment

author：hotspot 2025-10-06 09:54:50 - browse：28

Scientist walks up a strand of DNA -- First Opinion coverage from STAT — Adobe

Eli Lilly said Tuesday that it will pay $200 million to gene-editing firm Beam Therapeutics for Beam’s stake in Verve Therapeutics, another gene-editing company focused on treatments for heart disease.

The deal, which also includes future milestone payments, is evidence that despite the pressure on biotechnology stocks there is still interest in very early cutting-edge technologies among big pharmaceutical players. It also provides Beam, which announced on Oct. 19 that it would cut 100 jobs, or 20% of its workforce, to save cash, a large infusion of money.

“This is like a true win-win-win deal, which is rare in this business, but it’s really, really exciting to see,” said John Evans, Beam’s CEO, in an interview with STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

WSS

As health system earnings go up, health insurance stocks go down

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

The Bio Revolution is changing business and society

Congress: Prevent baby formula shortages by passing a new bill

Can gargling with Listerine treat gonorrhea of the mouth?

knowledge

entertainment

hotspot

Moonlake's readout produced a cash windfall. Risks remain

Can gargling with Listerine treat gonorrhea of the mouth?

Heart attack and stroke risk calculators need revising

PBM executives asked to testify by House panel

Drug repurposing or repositioning? The language matters

Clinicians often fail to acknowledge the pain caused by long Covid

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

The world needs the new pandemic treaty

Continuity nursing helped my family in our darkest PICU moments

GSK’s asthma push continues as drug succeeds in Phase 3 trials

knowledge

Warren pushes Witty on UnitedHealth's control over physicians

AI for drug discovery: Experts on separating hype from reality

Crowdfunding for medical bills sidesteps core problem, author says

PBM executives asked to testify by House panel

Protect nursing home residents from future pandemics

Achieving telehealth equity for people with hearing loss

knowledge

leisure time

entertainment

focus